These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1309850)

  • 1. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
    Marshall GS; Rabalais GP; Stout GG; Waldeyer SL
    J Infect Dis; 1992 Feb; 165(2):381-4. PubMed ID: 1309850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
    Marshall GS; Li M; Stout GG; Louthan MV; Duliège AM; Burke RL; Hunt LA
    Viral Immunol; 2000; 13(3):329-41. PubMed ID: 11016597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
    Alberola J; Tamarit A; Igual R; Navarro D
    J Clin Virol; 2000 Apr; 16(2):113-22. PubMed ID: 10720815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of glycoprotein gB-specific antibody and neutralizing activity during natural cytomegalovirus infection.
    Marshall GS; Stout GG; Knights ME; Rabalais GP; Ashley R; Miller H; Rossier E
    J Med Virol; 1994 May; 43(1):77-83. PubMed ID: 8083653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
    Yue Y; Zhou SS; Barry PA
    J Gen Virol; 2003 Dec; 84(Pt 12):3371-3379. PubMed ID: 14645918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease.
    Alberola J; Domínguez V; Cardeñoso L; López-Aldeguer J; Blanes M; Estellés F; Ricart C; Pastor A; Igual R; Navarro D
    J Med Virol; 1998 Aug; 55(4):272-80. PubMed ID: 9661835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.
    Cui X; Cao Z; Wang S; Lee RB; Wang X; Murata H; Adler SP; McVoy MA; Snapper CM
    Vaccine; 2018 Sep; 36(37):5580-5590. PubMed ID: 30082162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus.
    Siddiqui S; Hackl S; Ghoddusi H; McIntosh MR; Gomes AC; Ho J; Reeves MB; McLean GR
    Immunology; 2021 Mar; 162(3):314-327. PubMed ID: 33283275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Nelson CS; Huffman T; Jenks JA; Cisneros de la Rosa E; Xie G; Vandergrift N; Pass RF; Pollara J; Permar SR
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6267-6272. PubMed ID: 29712861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
    J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA.
    Zavaglio F; Fiorina L; Suárez NM; Fornara C; De Cicco M; Cirasola D; Davison AJ; Gerna G; Lilleri D
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
    Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
    J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.
    Shimamura M; Mach M; Britt WJ
    J Virol; 2006 May; 80(9):4591-600. PubMed ID: 16611919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M; Radsak K; Enders G; Reschke M
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of neutralizing antibody against human cytomegalovirus (HCMV) with DNA-mediated immunization of HCMV glycoprotein B in mice.
    Hwang ES; Kwon KB; Park JW; Kim DJ; Park CG; Cha CY
    Microbiol Immunol; 1999; 43(3):307-10. PubMed ID: 10338203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
    Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
    J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D; Lennette E; Tugizov S; Pereira L
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Effector Memory B-Cell Response to Envelope Glycoprotein B During Primary Human Cytomegalovirus Infection.
    Dauby N; Sartori D; Kummert C; Lecomte S; Haelterman E; Delforge ML; Donner C; Mach M; Marchant A
    J Infect Dis; 2016 May; 213(10):1642-50. PubMed ID: 26715677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.